Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Concert Pharmaceutic (CNCE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2020	12-2019	09-2019	06-2019	03-2019
Cash Flows From Operating Activities
Net Income	-20,477	-78,166	-57,679	-40,494	-21,826
Depreciation Amortization	328	651	357	243	150
Accounts receivable	71	-57	4	-23	4
Accounts payable and accrued liabilities	563	-217	207	-508	479
Other Working Capital	-2,619	16,048	13,671	14,404	15,057
Other Operating Activity	4,300	12,980	9,755	8,353	4,798
Operating Cash Flow	$-17,834	$-48,761	$-33,685	$-18,025	$-1,338

Cash Flows From Investing Activities
Change In Deposits	-59,517	83,268	48,380	43,368	42,390
PPE Investments	-112	-685	-520	-472	-315
Investing Cash Flow	$-59,629	$82,583	$47,860	$42,896	$42,075

Cash Flows From Financing Activities
Common Stock Issued	70,499	2,076	1,000	1,814	1,755
Common Stock Repurchased	N/A	-740	-741	-741	N/A
Other Financing Activity	0	115	1,180	0	0
Financing Cash Flow	$70,499	$1,451	$1,439	$1,073	$1,755

Beginning Cash Position	54,200	18,927	18,927	18,927	18,927
End Cash Position	47,236	54,200	34,541	44,871	61,419
Net Cash Flow	$-6,964	$35,273	$15,614	$25,944	$42,492

Free Cash Flow
Operating Cash Flow	-17,834	-48,761	-33,685	-18,025	-1,338
Capital Expenditure	-112	-685	-520	-472	-315
Free Cash Flow	-17,946	-49,446	-34,205	-18,497	-1,653